Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis
Combines bioproduction and pharma services to accelerate innovation in biologics manufacturing
WALTHAM, Mass., Sept. 9, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri.
The facility is adjacent to the company’s biologics manufacturing facility, which recently doubled production capacity with a $50 million expansion. The combined expertise from Thermo Fisher’s bioproduction and pharma services businesses will accelerate innovation and enhance productivity for biopharma companies, enabling them to meet the growing need for more flexible, scalable biologics development and manufacturing solutions.
“Our St. Louis site is among the world’s largest producers of biologics using single-use technology and the ideal location for this unique collaboration,” said Michael Shafer, senior vice president and president, pharma services, Thermo Fisher Scientific. “These complementary businesses will work together to develop innovative bioprocessing technologies, products and services. This will enhance bioprocess workflows and enable our customers to take their products to market faster and with greater efficiency.”
In 2019, four out of every 10 drugs under development were biologics-based and this growth continues to drive demand for innovation. The BCC will bring together the company’s leadership in GMP biologics manufacturing with its deep expertise in bioprocessing technologies including bioreactors, cell culture media, chromatography and analytical tools, among others. This collaboration will deliver new single-use bioprocessing technologies as well as drive critical process, data management and quality improvements that enable scale-up solutions for biopharma customers.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.
Media Contact Information:
Marcia Goff, Thermo Fisher Scientific
+1.508.902.7041
marcia.goff@thermofisher.com
Rachel Robbins, Greenough
+1.781.249.9490
rrobbins@greenough.biz
SOURCE Thermo Fisher Scientific
